Loading...
Genetic landscape of extreme responders with anaplastic oligodendroglioma
BACKGROUND: The NRG Oncology RTOG 9402 trial showed significant survival benefit in patients with 1p/19q co-deleted anaplastic oligodendrogliomas (AO) who received both radiation (RT) and chemotherapy (PCV regimen) versus RT alone. Substantial separation of the survival curves was only seen after 7....
Na minha lista:
Udgivet i: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Impact Journals LLC
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482595/ https://ncbi.nlm.nih.gov/pubmed/28388591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16773 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|